Maia BiotechnologyMAIA
13F holders, Q4 2024 (December 31)20holders +3
6new positions
4sold out
$1.98avg. 13F price*
At the end of Q4 2024, 20 institutions reported holding Maia Biotechnology Inc. (MAIA) in their 13F filings, up 3 from Q3 2024. 6 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($1.2M), Halter Ferguson Financial Inc. ($477K) and Geode Capital Management, LLC ($391K).
- Company
- Maia Biotechnology Inc.
- CUSIP
- 552641102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $123K |
| Exits | 4 | $140K |
All 13F filers, Q3 2024 → Q4 2024: 109,001 shares bought and 185,842 shares sold, net −76,841 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Vanguard Group Inc. | 0.00% | Add +2.9% | 582,507 | $1.2M |
| Halter Ferguson Financial Inc. | 0.20% | Reduce -36.1% | 240,818 | $477K |
| Geode Capital Management, LLC | 0.00% | Add +2.6% | 197,524 | $391K |
| BlackRock, Inc. | 0.00% | Add +6.3% | 84,785 | $168K |
| Centric Wealth Management | 0.04% | No change | 68,219 | $135K |
| State Street Corp. | 0.00% | Add +54.8% | 53,250 | $105K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 45,700 | $90K |
| Jane Street Group, LLC | 0.00% | New | 39,057 | $77K |
| Northern Trust Corp. | 0.00% | No change | 32,071 | $64K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 14,800 | $29K |
| Susquehanna International Group, LLP | 0.00% | New | 11,649 | $23K |
| Osaic Holdings, Inc. | 0.00% | New | 7,450 | $15K |
| Morgan Stanley | 0.00% | No change | 5,095 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +124.1% | 3,285 | $7K |
| Royal Bank of Canada | 0.00% | New | 3,000 | $6K |
| MAI Capital Management | 0.00% | New | 675 | $1K |
| Bernard Wealth Management Corp. | 0.00% | — | 500 | $990 |
| Tucker Asset Management LLC | 0.00% | New | 341 | $675 |
| Bank of America Corp. | 0.00% | Add +5.1% | 164 | $325 |
| JPMorgan Chase & Co. | 0.00% | Reduce -4.3% | 45 | $89 |
"% of holder's portfolio" is MAIA's weight in each manager's 13F, not the share of Maia Biotechnology Inc. the manager owns.